ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency

YONKERS, NY(Marketwired August 04, 2016) ContraFect Corporation(CFRX) (CFRXW), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for lifethreatening,
drugresistant infectious diseases, today announces that it has been granted Small and Medium Enterprise (SME) designation by the European Medicines Agency (EMA).

This entry was posted in Recent Development News: Q3 - 2016, Recent Developments. Bookmark the permalink.
Read Full Article »